Biocon chair Kiran Mazumdar-Shaw identifies successor as Indian pharma firm plans transition
05/05/2026 07:29
May 5 (Reuters) - Biocon founder Kiran Mazumdar-Shaw plans a gradual leadership transition over the next five years, with her niece Claire Mazumdar expected to take over as chair in a phased manner, she told Reuters. The succession plan was first reported by business magazine Fortune India in an interview with Mazumdar-Shaw. (Reporting by Rishika Sadam; Writing by Surbhi Misra ; Editing by Nivedita Bhattacharjee) ((Surbhi.Misra@thomsonreuters.com | X: https://twitter.com/SurbhiMisra_ |;))
Recent news on Biocon
See all newsBrief: Biocon Says Biocon Pharma Receives Health Canada Approval For Micafungin For Injection, USP, 50 Mg And 100 Mg
India's Biocon gains after Q4 results
Biocon's Mazumdar-Shaw sets out 5-year succession plan, names niece Claire as successor (updated)
Biocon chair Kiran Mazumdar-Shaw identifies successor as Indian pharma firm plans transition
Brief: Biocon Chair Kiran Mazumdar-Shaw Says Want Niece Claire Mazumdar To Succeed In A Well-Phased Manner Over A Five-Year Period